Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-10-30
2007-10-30
Seaman, Margaret D. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S248000, C514S267000, C514S450000, C514S454000, C514S468000, C514S291000, C514S293000, C544S234000, C544S250000, C544S251000, C546S089000, C546S083000, C549S354000, C549S359000, C549S460000, C549S461000
Reexamination Certificate
active
10598690
ABSTRACT:
A compound of the formula (I) (I) wherein the variables X1 to X6, Ra, Rb, R1 to R7 including R3′, E, p, j, y, z, A, B and C are as described or a pharmaceutically acceptable salt, solvate, enantiomer, racemate, diastereomer or mixtures thereof, useful for the treatment, prevention or amelioration of obesity and Related Diseases is disclosed
REFERENCES:
patent: 4678779 (1987-07-01), Meyers et al.
patent: 5532266 (1996-07-01), Gottschlich et al.
patent: WO 2004/026305 (2004-04-01), None
patent: WO 2004/080968 (2004-09-01), None
patent: WO 2004/080996 (2004-09-01), None
patent: WO 2005/061442 (2005-07-01), None
patent: WO 2005/066164 (2005-07-01), None
Brendle et al., antimicrobial agents and chemotherapy, 2002, vol. 46, pp. 797-807.
Broughton Howard Barff
Diaz Buezo Nuria
Mitch Charles Howard
Pedregal-Tercero Concepcion
Demeter John C.
Eli Lilly and Company
Ginah Francis O.
Rahmani Niloofar
Seaman Margaret D.
LandOfFree
Opioid receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Opioid receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Opioid receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3838159